Anbio BiotechnologyNNNN
13F holders, Q2 2026 (June 30)12holders +4
6new positions
2sold out
$13.71avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding Anbio Biotechnology Ltd. (NNNN) in their 13F filings, up 4 from Q1 2026. 6 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($367K), Bank of America Corp. ($184K) and BNP Paribas Financial Markets ($162K).
- Company
- Anbio Biotechnology Ltd.
- CUSIP
- G0367B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $344K |
| Exits | 2 | $3K |
All 13F filers, Q1 2026 → Q2 2026: 27,433 shares bought and 5,802 shares sold, net +21,631 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 26,736 | $367K |
| Bank of America Corp. | 0.00% | New | 13,419 | $184K |
| BNP Paribas Financial Markets | 0.00% | Add +13.5% | 11,800 | $162K |
| Marshall Wace, LLP | 0.00% | New | 11,502 | $158K |
| Morgan Stanley | 0.00% | Reduce -1.5% | 7,231 | $99K |
| UBS Group AG | 0.00% | Reduce -86.9% | 828 | $11K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -29.7% | 187 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 77 | $1K |
| JPMorgan Chase & Co. | 0.00% | New | 53 | $718 |
| Bare Financial Services, Inc | 0.00% | No change | 15 | $206 |
| Larson Financial Group LLC | 0.00% | New | 5 | $69 |
| Silver Grove Financial Group, Inc. | 0.00% | New | 4 | $55 |
"% of holder's portfolio" is NNNN's weight in each manager's 13F, not the share of Anbio Biotechnology Ltd. the manager owns.